Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

Bianca Weinstock-Guttman; Robert Zivadinov; Dana Horakova; Eva Havrdova; Jun Qu; Grace Shyh; Elizabeth Lakota; Kerri O'Connor; Darlene Badgett; Miriam Tamaño-Blanco; Michaela Tyblova; Sara Hussein; Niels Bergsland; Laura Willis; Jan Krasensky; Manuela Vaneckova; Zdenek Seidl; Murali Ramanathan

doi:10.1136/jnnp-2012-304740

Article info

Multiple sclerosis

Research paper

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

Authors

Bianca Weinstock-Guttman Department of Neurology, State University of New York, Buffalo, New York, USA PubMed articles Google scholar articles
Robert Zivadinov Department of Neurology, State University of New York, Buffalo, New York, USA Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, New York, USA PubMed articles Google scholar articles
Dana Horakova Department of Neurology, Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Eva Havrdova Department of Neurology, Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Jun Qu Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Grace Shyh Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Elizabeth Lakota Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Kerri O'Connor Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Darlene Badgett Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Miriam Tamaño-Blanco Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles
Michaela Tyblova Department of Neurology, Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Sara Hussein Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, New York, USA PubMed articles Google scholar articles
Niels Bergsland Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, New York, USA PubMed articles Google scholar articles
Laura Willis Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, New York, USA PubMed articles Google scholar articles
Jan Krasensky Department of Radiology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Manuela Vaneckova Department of Radiology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Zdenek Seidl Department of Radiology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic PubMed articles Google scholar articles
Murali Ramanathan Department of Neurology, State University of New York, Buffalo, New York, USA Department of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA. PubMed articles Google scholar articles

Correspondence to Professor Murali Ramanathan, Department of Pharmaceutical Sciences, State University of New York, Buffalo, 355 Kapoor Hall, Buffalo, NY 14214-8033, USA; Murali{at}Buffalo.Edu

View Full Text

Citation

Weinstock-Guttman B, Zivadinov R, Horakova D, et al

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

Journal of Neurology, Neurosurgery & Psychiatry 2013;84:1186-1191.

Publication history

Received December 7, 2012
Revised March 2, 2013
Accepted March 20, 2013
First published April 17, 2013.

Online issue publication

April 04, 2017

Article Versions

Previous version (13 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password